Pictet Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $78.9M | Sell |
|
|||||
|
2025
Q4 | $110M | Buy |
|
|||||
|
2025
Q3 | $97.3M | Sell |
|
|||||
|
2025
Q2 | $87.5M | Buy |
|
|||||
|
2025
Q1 | $43.1M | Sell |
|
|||||
|
2024
Q4 | $83.4M | Sell |
|
|||||
|
2024
Q3 | $97M | Sell |
|
|||||
|
2024
Q2 | $120M | Sell |
|
|||||
|
2024
Q1 | $149M | Sell |
|
|||||
|
2023
Q4 | $160M | Buy |
|
|||||
|
2023
Q3 | $117M | Buy |
|